E-Mail
Air quality in Spain temporarily improved during the first wave of COVID-19, largely as a result of mobility restrictions. Until recently, however, the effect of this improvement on the health of the population was poorly understood. A new study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the la Caixa Foundation, together with the Barcelona Supercomputing Center (BSC-CNS), has estimated that this improvement in air quality prevented around 150 premature deaths in Spain s provincial capital cities.
Several analyses have estimated the mortality reduction from improved air quality during lockdown periods in China and Europe and found that a substantial number of premature deaths have been avoided. The new study, published in
Dr. Kirsty Short, a virologist and senior lecturer at
“Recent phase 2/3 data from both Novavax and Johnson & Johnson suggest reduced protection against the South African variant,” Dr. Short reports.
“The Oxford/AstraZeneca vaccine group also released data suggesting its vaccine offers only minimal protection against mild-moderate disease caused by this variant.”
“It’s important to recognize ‘reduced protection’ doesn’t mean
no protection at all, and that data are still emerging” and
“What’s more, numerous vaccine manufacturers are now investigating whether tweaks to the vaccines can improve their performance against the emerging variants,” added Dr. Short.
Dr. Kirsty Short, a virologist and senior lecturer at The University of Queensland
Published: - May 07, 2021
The fourth wave of the pandemic is affecting the mental health of people around the world, we are submerged in a barrage of bad news everywhere, in the media, casual conversations, and social networks.
The Woman Post | Blanca Mery Sanchez (@soyblancamery)
Listen to this article Your browser does not support the audio tag.
This means that global stress is reaching levels never seen before and that its effects are seen for several years after the COVID-19 pandemic has passed.
Universities and research centers around the world in Chile, Northern Ireland Assembly, Spain (Barcelona Institute of Global Health) are warning about the urgent need to act now to improve the mental health of the most vulnerable people: children, the elderly, and women, who by our biology already have a greater risk of suffering from anxiety and depression we must be the center of interventions.
Share this article
Share this article
VANCOUVER, BC, May 4, 2021 /PRNewswire/ - Mountain Valley MD (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) announced it has filed a novel cancer adjuvant patent related to breast cancer, metastatic melanoma, and lung carcinoma.
Mountain Valley MD is a biotech and life sciences company implementing patented Quicksome oral drug formulation and delivery technologies and its Quicksol solubilization technology.
MVMD s core technology applied to the Ivermectin drug is unique in that it only uses excipients (substances formulated alongside the active ingredient) that are
currently approved by the FDA.
Concurrent with its novel cancer adjuvant patent, MVMD is beginning pre-clinical trials with third-party cancer Contract Research Organizations (CROs).
Being exposed to higher air pollution levels for a month could speed up cognitive decline in older men, a study has suggested.
Researchers found people performed poorer in recall and reaction time tests if air pollution levels increased in the 28 days before they were quizzed.
But men taking commonly prescribed anti-inflammatory drugs such as aspirin were less affected, scientists discovered.
The study, by Peking University in China, looked at a cohort of nearly 1,000 men with an average age of 70 who lived in Boston in the US.
Cognitive function was assessed using a series of tests over time to determine their memory, attention and learning.